BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with th

BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

ID: 271060

(Thomson Reuters ONE) -
BB Biotech AG /
BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities
Trading Act) with the aim of pan-European distribution
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Pursuant to article 26 sec 1 clause 2 WpHG, BB Biotech AG, Schaffhausen,
Switzerland, herby reports that it decreased its holding in own shares to below
10% and 5% respectively of the proportion of voting rights as of June 17, 2013
(a total of 442 245 shares / 3.73% of the proportion of voting rights) due to a
capital reduction.

Thereof, 2.68% of the proportion of voting rights (a total of 317 245 shares)
are held through its wholly-owned subsidiary Biotech Target N.V., Curaçao.


For further information:
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht / Zürich
Thomas Egger, Tel. +41 44 267 67 00.

Schaffhausen, June 19, 2013
BB Biotech AG



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: BB Biotech AG via Thomson Reuters ONE
[HUG#1710321]






Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Tessenderlo Group completes sale of its Compounds activities MUSIC Group Pro Ramps Up in APAC; Scores Rowlands to Lead
Bereitgestellt von Benutzer: hugin
Datum: 19.06.2013 - 07:31 Uhr
Sprache: Deutsch
News-ID 271060
Anzahl Zeichen: 1602

contact information:
Town:

Schaffhausen



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 185 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution"
steht unter der journalistisch-redaktionellen Verantwortung von

BB Biotech AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von BB Biotech AG



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z